Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
주식 순위 #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
주가
$0.0202
마지막 동기화: 2024-11-19
시가총액
$44.67K
변동 (1일)
-0.49%
변동 (1년)
0.00%
국가
IL
거래 Notable Labs, Ltd. (NTBL)

카테고리

Notable Labs, Ltd. (NTBL)의 EPS
June 2024 기준 EPS TTM: $-0.97
Notable Labs, Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.97입니다. 2022년 말에는 회사의 EPS가 $-6.50였으며, 이는 2021년의 EPS $-0.22와 증가입니다.
Notable Labs, Ltd.의 EPS 기록 (2015 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.97 -80.72%
2023 $-5.03 -22.62%
2022 $-6.50 2,854.55%
2021 $-0.22 -54.17%
2020 $-0.48 26.32%
2019 $-0.38 -38.71%
2018 $-0.62 67.57%
2017 $-0.37 -42.19%
2016 $-0.64 -12.33%
2015 $-0.73 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -1,885.57%
US
$27.74 -2,959.79%
NL
- -
CH
- -
KR
$13.70 -1,512.38%
BE